How Medical Affairs Becomes the Connector with Sonia Talwar
April 23, 2026
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sonia Talwar, Senior Director of Scientific Communications and Medical Information in Hematology/Oncology at Pharmacosmos Therapeutics, to discuss how medical affairs can evolve from a reactive support function into a true strategic connector.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sonia Talwar, Senior Director of Scientific Communications and Medical Information in Hematology/Oncology at Pharmacosmos Therapeutics, to discuss how medical affairs can evolve from a reactive support function into a true strategic connector.
What You’ll Learn:
- How medical information teams sit on a goldmine of unfiltered HCP insights
- Why that data deserves a seat at the strategy table
- How to reposition medical information as strategic intelligence
- Practical AI applications that work today
Sonia Talwar is the Senior Director of Scientific Communications and Medical Information in Hematology/Oncology at Pharmacosmos Therapeutics. Sonia has spent more than 15 years building and scaling Medical Affairs capabilities across pharma with deep expertise in medical information, publication strategy, scientific communications, and evidence planning. What makes Sonia’s perspective especially compelling is her ability to connect functions that are often siloed : Medical, Market Access, Commercial, HEOR, and Scientific Communications.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.
Episode Resources:
Episode Resources:
Pharma Sessions is handcrafted by our friends over at: fame.so